Lv1
40 积分 2023-02-02 加入
Treatments for pulmonary arterial hypertension: navigating through a network of choices
3个月前
已完结
Relationship of TAPSE Normalized by Right Ventricular Area With Pulmonary Compliance, Exercise Capacity, and Clinical Outcomes
3个月前
已完结
Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults With Pulmonary Arterial Hypertension
3个月前
已完结
PDZ-Binding Kinase, a Novel Regulator of Vascular Remodeling in Pulmonary Arterial Hypertension
3个月前
已完结
Asymmetric Dimethylarginine and NT-proBNP Levels Provide Synergistic Information in Pulmonary Arterial Hypertension
3个月前
已完结
Pharmacological Agents and Potential New Therapies in Pulmonary Arterial Hypertension
4个月前
已完结
Risk stratification refinements with inclusion of haemodynamic variables at follow-up in patients with pulmonary arterial hypertension
4个月前
已完结
Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial
4个月前
已完结
Interest of TAPSE/sPAP ratio for noninvasive pulmonary arterial hypertension risk assessment
4个月前
已完结
Anticoagulation in pulmonary arterial hypertension - association with mortality, healthcare utilization, and quality of life: The Pulmonary Hypertension Association Registry (PHAR)
4个月前
已完结
皖公网安备34019202002308
